Clinical Trials Browser

Phase 4 × Docosahexaenoic Acids × Clear all

NCT06918080 2025-04-09

Hepatoprotective Measures for Children at High Risk of NAFLD

Phase 4 Active not recruiting

LymphoidOtherOther hematologic neoplasm

Obesity, Overweight, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Non-alcoholic Fatty Liver Disease

NCT01733147 2022-01-11

Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids

Phase 4 Completed

60 enrolled 6 charts

GastrointestinalOther

Barrett Esophagus, Obesity